Primary percutaneous coronary angioplasty (PTCA):

Carried within few hours of Ml. Has emerged as an alternative to thrombolytic therapy and is usually the preferred recanalization strategy with better outcome.

Thrombolytic therapy only in patient with STEMI:

Indications

  • Given with in the first 12 hr. of chest pain, can cause reperfusion, limitation of infraction size and left ventricular dysfunction and reducing mortality.
  • Streptokinase, urokinase, acylated plasminogen streptokinas activator complex “APSAC”, Pro- urokinase, alteplase, tenecteplae

Contraindications:

The choice between PTCA vs thrombolytic therapy depends on the location and resources